Sphere-forming capacity of PTX-resistant breast cancer stem-like cells is dramatically reduced with MCM10 knockdown.10 Bao et al11 reported that in patients who acquired lapatinib resistance, increased MCM10 is a poor prognostic factor. The gene discussed is MCM10; the disease is breast carcinoma.